Our Team

We leverage Big Data to save lives.

Experienced, Multidisciplinary Team of Clinicians and AI Scientists

CEO, Co-Founder

Gal Salomon

Prior to founding CLEW, Mr. Salomon founded Sansa Security (formerly Discretix) and led the company as CEO from inception until August 2010. He then served as its active Chairman until the acquisition by ARM. During this time, he was a Venture Partner at Pitango Venture Capital. Prior to founding Discretix, Mr. Salomon served in multiple positions in DSP Communications (NYSE: DSP) and Intel. Mr. Salomon holds a B.Sc. in Electrical Engineering and an MBA.

VP Clinical Affairs, Co-Founder

Avigdor Faians

Mr. Faians brings more than twenty years of experience in design management and system architecture for the networking, communications and consumer electronics markets. He served as CTO of WAN communications at Mindspeed Technologies and VP R&D at Techtium. Mr. Faians holds a B.Sc. in Physics, cum laude, from Ben-Gurion University of the Negev and an Electrical Engineering degree from the Technion – Israel Institute of Technology.

Chief Scientist

Prof. Assaf Zeevi

Prof. Ze’evi is the Vice Dean for Research and the Henry Kravis Professor of Business at the Graduate School of Business, Columbia University. His research is broadly focused on the formulation and analysis of mathematical models of complex systems. Ze’evi received his B.Sc. and M.Sc. (1997) Cum Laude from the Technion – Israel Institute of Technology, and subsequently his Ph.D. (2001) from Stanford University. In 2001, he joined the faculty of the Business School at Columbia University.

Medical Director

Dr. Itai Pessach

Dr. Pessach is an Assistant Professor of Pediatrics at the Tel-Aviv University and a Deputy Director at Safra Children’s Hospital, Sheba Medical Center. He is certified in allergy immunology and in pediatric critical care. He has a broad background in basic and clinical research and has published extensively in the fields of pediatric immunology and critical care. Dr. Pessach holds MD and PhD degrees from the Ben-Gurion University and has trained both at Sheba Medical Center and at Children’s Hospital Boston, Harvard Medical School.

VP Clinical Development

Dr. Ofer Chen, MD MPA

Dr. Chen received his M.D. from the Hebrew University of Jerusalem School of Medicine, and is certified in both internal medicine and in healthcare management. He has a Master’s degree in public administration from Harvard University’s Kennedy School of Government, and is a Fellow of Harvard’s Center for Public Leadership and a Wexner Foundation Fellow.
Prior to joining Clew Medical, Ofer has served in various leadership positions in the healthcare system, including deputy director of Assuta Ashdod University Hospital and Head of Community Healthcare in Maccabi Healthcare Services, Israel’s second largest HMO.

VP Research & Development

Elan Hershcovitz

Elan Hershcovitz joined CLEW as VP of R&D in 2021. Mr. Hershcovitz is an IT and cyber security specialist, with vast experience leading mission-critical software development and research projects in information security, computer vision, machine learning, and IoT. Prior to joining CLEW, Mr. Hershcovitz served as Sr. Director of Engineering at Snyk, as VP R&D at Validoo, Sr. Director & Divisional CTO of Eastman Kodak and Sr. Director of R&D at CA Technologies.  Mr. Hershcovitz holds a bachelor’s degree in Computer Science and an MBA in Information Technology from the University of Derby, UK.

Vice President Of Business Development

Joel Gochberg

Joel Gochberg joined CLEW in November 2020 after 14 years participating in and leading sales in the Tele-ICU business. Other experience includes sales and business development in Electronic Health Records, product management, and marketing. Mr. Gochberg has 10 years’ experience as a software engineer for real-time critical care clinical information systems, so is well versed with CLEW Medical’s domain. Mr. Gochberg was founder and President of ACT/PC, Chief Technology Officer for Clinical Dimensions, Inc., and has also worked for MedicaLogic/Medscape, GE, IDX and Philips. Mr. Gochberg holds a BS in Computer Science from the University of Wisconsin-Madison, and an MBA from Bethel University.

Director of Customer Success

Peggy Pilon

Peggy Pilon, RN, BSN joined CLEW in November of 2021 as the Director of Client Success. She has spent multiple years in Virtual Health and served as the Senior Global Clinical Leader of Philips’ Telehealth solution. In addition, Peggy has over 20 years of Critical Care and Emergency Medicine experience. Peggy is an established Nurse Leader, including participating and leading the clinical staff, as Chief Nursing Officer at Regency Hospital. Ms. Pilon was also the Central Area Senior Clinical Region Manager for Baxter Healthcare, where she was responsible for Customer Success and Implementations for 23 states in the US. Peggy holds a BSN in Nursing from the University of Wisconsin-Madison.

VP Product

Noa Berger-Kurtzer

Ms. Noa Berger-Kurtzer is a seasoned Product Executive with over 10 years of experience in introducing innovative clinical products into the global healthcare ecosystem. Prior to joining CLEW in 2017, Noa served as a Product Manager at Change Healthcare (fka McKesson). Noa holds a B.Sc. in Bio Medical Engineering, from Tel Aviv University in Israel.


VP Finance

Daniel Almog

Mr. Almog is an experienced Finance Executive with specialized expertise in auditing NASDAQ pharmaceutical companies and consulting for numerous IPOs at TASE. Prior to joining CLEW, Daniel served as Controller at A2Z Technologies and as senior accounting associate at PwC. Daniel holds a Law degree from Reichman University (IDC Herzliya), Israel.


Advisory Board

Emory University School of Medicine

James M. Blum, MD

Dr. Blum is an NIH funded investigator and recognized expert in perioperative ARDS. He received national awards from the IARS and SOCCA. He served on several committees at SCCM, USCIITG, and has been an invited lecturer at multiple institutions, USCIITG, SCCM, IARS, and ASA. He is an active reviewer for multiple journals in both anesthesiology and critical care medicine. Blum is recognized as a national leader in critical care. His research focuses on perioperative lung injury and large datasets for outcomes research and waveform analysis.


Beth Israel Deacones, Boston, MA

Daniel Talmor, MD

Prof. Talmor is Professor of Anesthesia at Harvard Medical School and Chairman for Critical Care Medicine in the Department of Anesthesia, Critical Care, and Pain Medicine at Beth Israel Deaconess Medical Center in Boston. His fields of research include intensive care outcomes and echocardiography in the ICU. He also brings an interest in the application of data and analytics to the improvement of patient outcomes. Dr. Talmor is a graduate of Ben-Gurion University Medical School and has lectured extensively both nationally and internationally on topics relating to anesthesia and critical care.

Brigham & Women, Boston, MA

David Bates, MD

Prof. Bates is Senior Vice President for Quality and Safety and Chief Quality Officer for both the Brigham and Women’s Hospital and the Brigham and Women’s Physicians Organization. He is a practicing general internist who maintains positions at Brigham and Women’s Hospital, Harvard Medical School and Harvard School of Public Health, where he co-directs the Program in Clinical Effectiveness. Prof. Bates is a graduate of Stanford University and the Johns Hopkins School of Medicine.

Assuta Medical Center, Israel

Eran Segal, MD

Dr. Segal is the Director for the department of Anesthesia, Intensive Care and Pain Medicine at Assuta Medical Centers in Israel. Prior to joining Assuta, Dr. Segal was the Director of Critical Care at Sheba Medical Center in Israel.

Tel Aviv Medical Center, Israel

Idit Matot, MD

Prof. Matot is the Chairwoman of the Division of Anesthesia, Critical Care and Pain Medicine at Tel Aviv Medical Center in Israel. She received her M.D from the Hebrew University School of Medicine, Jerusalem and was a senior anesthesiologist for 14 years at Hadassah Medical Center. Her research focus is perioperative outcome (clinical) and liver perfusion and regeneration (experimental).

University of Chicago, Chicago, IL

Michael F. O’Connor, MD

Prof. O’Connor is the Director of Critical Care Medicine at the University of Chicago Medical Center. As an anesthesiologist and intensivist, Dr. O’Connor spent much of the past 23 years working in intensive care units, including the Burn ICU, Surgical ICU, Medical ICU, and Cardiothoracic ICU. His wide range of clinical interests includes improving the performance of alarms in the ICU and predicting decompensation in ward patients. As a leader of the initiative to create ACLS guidelines for the perioperative setting, Dr. O’Connor has authored guidelines as well as multiple books and chapters on various aspects of Critical Care.

Harvard Medical School

John D. Halamka MD

Dr. Halamka currently serves as Executive Director of Beth Israel Lahey Health Exploration Center. He also leads innovation for Beth Israel Lahey Health, serves as Chairman of the New England Healthcare Exchange Network (NEHEN), is the International Healthcare Innovation professor at Harvard Medical School, and is a practicing emergency physician. Previously, Dr. Halamka served as CIO of Beth Israel Deaconess Healthcare System.

Mike Murphy

Mike Murphy retired after 22 years as President and Chief Executive Officer of Sharp HealthCare in 2019. Sharp is a large integrated healthcare delivery organization and is San Diego’s  largest private employer with over 18,000 employees and 3,000 physicians, and has annual revenues approaching $4 billion.  Prior to joining Sharp 28 years ago, Mike was a partner with Deloitte and Touche and worked for over 12 years in the public accounting industry, with an emphasis on the health care industry. Murphy is a graduate of California State University at Long Beach and is a Certified Public Accountant. He currently serves on the Boards of Directors of Macro Health, Providence St. Joseph Health and Jack in the box. He has served on numerous community and professional boards including Chair of the State of California Chamber of Commerce in 2016.

Ron Greeno, MD, FCCP, MHM

Ron Greeno is a veteran physician executive with 25 years of experience in the hospitalist physician practice industry. Ron was the founder of Cogent Healthcare and served as Chief Medical Officer and the company’s first EVP of Strategy and Innovation for 17 years. Following the merger of Cogent Healthcare with Sound Physicians, Ron joined IPC Healthcare as its first ever Chief Strategy Officer, prior to its acquisition by Team Health. Ron is also past President and current Sr. Advisory for Government Relations for the Society of Hospital Medicine.

Board of Directors

CEO, Co-Founder

Gal Salomon

Prior to founding CLEW, Mr. Salomon founded Sansa Security (formerly Discretix) and led the company as CEO from inception until August 2010. He then served as its active Chairman until the acquisition by ARM. During this time, he was a Venture Partner at Pitango Venture Capital. Prior to founding Discretix, Mr. Salomon served in multiple positions in DSP Communications (NYSE: DSP) and Intel. Mr. Salomon holds a B.Sc. in Electrical Engineering and an MBA.

Barbara N. Lubash

Barbara has been a member of Clew’s  board of directors since 2018.  She also serves on corporate boards of HicuityHealth, and CareConnectMD. She is Vice Chair of the Board of SolveME/CFS, and is a member of the MassGeneralBrigham Innovation Growth Board, the Health Policy and Management Executive Council of the Harvard T.H. Chan School of Public Health, and the STEMAdvantage Advisory Board.

In her prior career as a health care executive, and later as a venture capitalist, Ms. Lubash led and advised innovative healthcare technology and services organizations. She was a founder and Managing Director of Versant Ventures, and before that was a Venture Partner at Crosspoint Ventures. Prior corporate boards include CodeRyte (acq 3M), Cogent Healthcare (acq Sound Physicians), Redbrick Health (acq Virgin Pulse), Titan Health (acq USPI), and Vantage Oncology (acq McKesson). She was Board Chair of the California HealthCare Foundation where she earlier led the formation of the Foundation’s PRI Innovation Fund). Ms. Lubash held prior operating roles at PacifiCare (now United), PHCS (PPO), and Hewlett Packard.  She received a BS from Tufts University, and a Master’s in Health Policy and Management from Harvard Chan School of Public Health.

Ittai Harel

Ittai Harel is a Managing General Partner at Pitango Venture Capital.
He brings 15 years of operating and management roles experience, and over ten years of experience in venture capital. His investment focus is on venture stage investments in Tech & Healthcare and includes Digital Health, Health-IT and MedTech.

Before joining Pitango, Ittai headed up Corporate Development at Nektar Therapeutics (NASDAQ: NKTR) and served as Executive Vice President at IDGene Pharmaceuticals.

He also served as Vice President of Business Development at IDEXX Laboratories (NASDAQ: IDXX).

Ittai currently serves on the Board of Directors of LifeBond, DouxMatokEarlySenseMedisafeClew Medical and Vertos Medical, and serves as Chairman of the Board at LifeBond and EarlySense
Ittai holds a B.Sc. in Chemical Engineering and Biotechnology from Ben-Gurion University, and an MBA from the MIT Sloan School of Management.

Ariel Moses

Managing General Partner, Agate JT healthcare fund and MaC Fund LP, board member in medical tech companies. 25 years of experience in corporate finance and investments. Former founder and CEO of Clal TIS fintech company, part of the Clal finance group. Former VP analytics and marketing Clal Factoring, lead analyst Mercantile discount bank. Board member in healthcare startups. Former founder/Co-CEO in a fintech startup. . 12 years of VC professional, leading investments to exits. BA economics and LLB.

Pierre-Yves Antier

Graduate engineer with a Master’s degree in actuarial science, Pierre-Yves Antier has more than 15 years of experience in the insurance industry with strong international background. In 2014, he joined SHAM, now RELYENS Group, as Head of International Development to implement insurance and risk management activities for Healthcare actors in Spain, Italy and Germany. In connection with the new strategy of RELYENS Group, in January 2019, he assume the position of Head of Strategy, Innovation and Transformation to consider the evolution of the client and insurance universe for Healthcare actors and local government